Cargando…
Model Optimization and In Silico Analysis of Potential Dipeptidyl Peptidase IV Antagonists from GC-MS Identified Compounds in Nauclea latifolia Leaf Extracts
Dipeptidyl peptidase IV (DPP-IV) is a pharmacotherapeutic target in type 2 diabetes. Inhibitors of this enzyme constitute a new class of drugs used in the treatment and management of type 2 diabetes. In this study, phytocompounds in Nauclea latifolia (NL) leaf extracts, identified using gas chromato...
Autores principales: | Iheagwam, Franklyn Nonso, Ogunlana, Olubanke Olujoke, Chinedu, Shalom Nwodo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929178/ https://www.ncbi.nlm.nih.gov/pubmed/31775302 http://dx.doi.org/10.3390/ijms20235913 |
Ejemplares similares
-
Nauclea latifolia Sm. Leaf Extracts Extenuates Free Radicals, Inflammation, and Diabetes-Linked Enzymes
por: Iheagwam, Franklyn Nonso, et al.
Publicado: (2020) -
Type 2 Diabetes Mellitus Mediation by the Disruptive Activity of Environmental Toxicants on Sex Hormone Receptors: In Silico Evaluation
por: Iheagwam, Franklyn Nonso, et al.
Publicado: (2021) -
Counteractive role of Terminalia catappa leaf extract on hematological and coagulation disturbance in Type 2 diabetic rats
por: Iheagwam, Franklyn Nonso, et al.
Publicado: (2023) -
Terminalia catappa Extract Palliates Redox Imbalance and Inflammation in Diabetic Rats by Upregulating Nrf-2 Gene
por: Iheagwam, Franklyn Nonso, et al.
Publicado: (2021) -
Terminalia catappa aqueous leaf extract reverses insulin resistance, improves glucose transport and activates PI3K/AKT signalling in high fat/streptozotocin-induced diabetic rats
por: Iheagwam, Franklyn Nonso, et al.
Publicado: (2022)